Form 8-K - Current report:
SEC Accession No. 0000950170-23-007983
Filing Date
2023-03-15
Accepted
2023-03-15 08:31:11
Documents
54
Period of Report
2023-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prld-20230315.htm   iXBRL 8-K 73076
2 EX-99.1 prld-ex99_1.htm EX-99 341135
3 EX-99.2 prld-ex99_2.htm EX-99 31837
4 EX-99.3 prld-ex99_3.htm EX-99 28860
5 GRAPHIC img1470765_0.jpg GRAPHIC 9445
6 GRAPHIC img268059179_0.jpg GRAPHIC 9445
7 GRAPHIC prld-ex99_2s1.jpg GRAPHIC 379713
8 GRAPHIC prld-ex99_2s2.jpg GRAPHIC 624567
9 GRAPHIC prld-ex99_2s3.jpg GRAPHIC 315715
10 GRAPHIC prld-ex99_2s4.jpg GRAPHIC 318049
11 GRAPHIC prld-ex99_2s5.jpg GRAPHIC 323077
12 GRAPHIC prld-ex99_2s6.jpg GRAPHIC 421947
13 GRAPHIC prld-ex99_2s7.jpg GRAPHIC 323051
14 GRAPHIC prld-ex99_2s8.jpg GRAPHIC 317741
15 GRAPHIC prld-ex99_2s9.jpg GRAPHIC 315397
16 GRAPHIC prld-ex99_2s10.jpg GRAPHIC 412433
17 GRAPHIC prld-ex99_2s11.jpg GRAPHIC 342432
18 GRAPHIC prld-ex99_2s12.jpg GRAPHIC 398744
19 GRAPHIC prld-ex99_2s13.jpg GRAPHIC 340396
20 GRAPHIC prld-ex99_2s14.jpg GRAPHIC 379362
21 GRAPHIC prld-ex99_2s15.jpg GRAPHIC 315892
22 GRAPHIC prld-ex99_2s16.jpg GRAPHIC 310306
23 GRAPHIC prld-ex99_2s17.jpg GRAPHIC 349563
24 GRAPHIC prld-ex99_2s18.jpg GRAPHIC 325161
25 GRAPHIC prld-ex99_2s19.jpg GRAPHIC 356131
26 GRAPHIC prld-ex99_2s20.jpg GRAPHIC 341758
27 GRAPHIC prld-ex99_2s21.jpg GRAPHIC 353836
28 GRAPHIC prld-ex99_2s22.jpg GRAPHIC 326233
29 GRAPHIC prld-ex99_2s23.jpg GRAPHIC 386288
30 GRAPHIC prld-ex99_2s24.jpg GRAPHIC 396393
31 GRAPHIC prld-ex99_2s25.jpg GRAPHIC 333298
32 GRAPHIC prld-ex99_2s26.jpg GRAPHIC 315727
33 GRAPHIC prld-ex99_2s27.jpg GRAPHIC 308603
34 GRAPHIC prld-ex99_2s28.jpg GRAPHIC 419256
35 GRAPHIC prld-ex99_2s29.jpg GRAPHIC 320261
36 GRAPHIC prld-ex99_2s30.jpg GRAPHIC 410341
37 GRAPHIC prld-ex99_2s31.jpg GRAPHIC 356914
38 GRAPHIC prld-ex99_2s32.jpg GRAPHIC 392330
39 GRAPHIC prld-ex99_2s33.jpg GRAPHIC 334638
40 GRAPHIC prld-ex99_2s34.jpg GRAPHIC 336669
41 GRAPHIC prld-ex99_2s35.jpg GRAPHIC 400986
42 GRAPHIC prld-ex99_2s36.jpg GRAPHIC 340608
43 GRAPHIC prld-ex99_2s37.jpg GRAPHIC 386913
  Complete submission text file 0000950170-23-007983.txt   19018389

Data Files

Seq Description Document Type Size
44 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prld-20230315_pre.xml EX-101.PRE 11109
45 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prld-20230315.xsd EX-101.SCH 2465
46 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prld-20230315_lab.xml EX-101.LAB 17736
48 EXTRACTED XBRL INSTANCE DOCUMENT prld-20230315_htm.xml XML 4706
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 23733403
SIC: 2834 Pharmaceutical Preparations